ADM Reports Second Quarter Earnings per Share of $2.18, $2.15 on an Adjusted Basis

Net earnings and adjusted earnings of about $1.2 billion Adjusted ROIC of 11.6% CHICAGO–(BUSINESS WIRE)–ADM (NYSE: ADM) today reported financial results for the quarter ended June 30, 2022. “Our second quarter adjusted earnings per share of $2.15 reflect our team’s strong execution, delivering nutrition to billions of people around the globe,” said Chairman and CEO … [Read more…]

Carmot Therapeutics closes $160 million Series D financing to advance clinical pipeline of novel incretin receptor modulators

BERKELEY, Calif.–(BUSINESS WIRE)–Carmot Therapeutics, Inc., a clinical-stage biotechnology company applying its proprietary drug discovery platform, Chemotype Evolution, to discover and develop disease-modifying therapies in metabolic disease and cancer, announced today a $160 million Series D financing. The funding will support the completion of phase 2 studies for CT-388, a once weekly, dual modulator of the … [Read more…]

Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures

LEWISVILLE, TEXAS–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos™ Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute for spine and orthopedic procedures. This allograft is prepared by MTF Biologics through a proprietary process that … [Read more…]

Generate Biomedicines Expands Leadership Team with the Addition of Chief Medical Officer Alexandra Snyder, M.D.

Dr. Snyder brings robust clinical development expertise from Two River and Merck & Co., Inc. SOMERVILLE, Mass.–(BUSINESS WIRE)–Generate Biomedicines, whose machine learning-powered generative biology platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics, today announced that Alexandra Snyder, M.D. has been named Chief Medical Officer to … [Read more…]

Head and Neck Cancer Diagnostics Market – Global Industry Analysis, Trends, and Forecasts to 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Head and Neck Cancer Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028” report has been added to ResearchAndMarkets.com’s offering. The report predicts the global head and neck cancer diagnostics market to grow with a CAGR of 11% over the forecast period from 2022-2028. The report on the global … [Read more…]

Alzheon to Present Industry-Leading Phase 2 Biomarker and Clinical Data with ALZ-801 (Valiltramiprosate) Oral Tablet at 2022 Alzheimer’s Association International Conference

New Results Position ALZ-801 to Potentially Become the First Oral Agent that Can Slow or Even Stop and Prevent Alzheimer’s Pathology in Patients and Healthy Individuals at Risk for the Disease Several-Fold Greater Reduction on P-tau181 Compared to Anti-Amyloid Antibodies Validates Superior Clinical Benefit from Prior Studies in Alzheimer’s Patients Significant Improvement on Memory Tests … [Read more…]

Element Nutritional Sciences Launches Clinical Strength Rejuvenate™ for Institutional Market

BURLINGTON, Ontario–(BUSINESS WIRE)–$ELMT—Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased to announce that it has completed commercialization for its Clinical Strength Rejuvenate™ formulation. The 15-gram drink mix is backed by two U.S. patents and is clinically proven to speed recovery after surgery as well as prevent muscle loss during bed … [Read more…]

HealthTrust Performance GroupSM Honors Members for Excellence, Sustainability and Innovation

NASHVILLE, Tenn.–(BUSINESS WIRE)–Six HealthTrust member organizations have been singled out for supply chain excellence, sustainability and innovation benefitting their patients, communities and stakeholders. Recipients of the annual Member Recognition Awards – the most prestigious honors presented by HealthTrust Performance Group – were announced last evening at HealthTrust University conference in Nashville. David Osborn, Ph.D., senior … [Read more…]

European Hospital Directory 2022: List of the Largest 6000 Hospitals Ranked by Revenue in $USm – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Database of Hospitals in Europe” database has been added to ResearchAndMarkets.com’s offering. The Database of Hospitals in Europe is an Excel spreadsheet containing a list of the largest 6000 Hospitals in Europe. Each of our company lists displays the leading companies ranked by revenue in $USm. Each Excel file contains the following: Company … [Read more…]

Checkpoint Inhibitors Global Market Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Checkpoint Inhibitors Global Market Report 2022: By Drug, By Application, By End-Users” report has been added to ResearchAndMarkets.com’s offering. Checkpoint Inhibitors Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global checkpoint inhibitors market. This report focuses on checkpoint inhibitors market which … [Read more…]